MiR-19a suppresses ferroptosis in colorectal cancer by modulating iron metabolism and inhibiting the ferroptosis-inducing factor iron-responsive element-binding protein 2 (IREB2) (Fan et al., 2022). The gene discussed is IREB2; the disease is colorectal cancer.